Characteristic | Findings—spine (n = 41 studies) | Findings—hip (n = 12 studies) |
---|---|---|
Age (years) | Range of reported mean values = 9.9 to 41.4 Not reported = 6 (14.6%) | Range of mean values = 6.5 to 11.1 Not reported = 1 (8.3%) |
Sex | Range of proportions (% female) = 38.6 to 89.2 Not reported = 12 (29.3%) | Range of proportions (% female) = 35.0 to 69.1 Not reported = 0 |
Functional level | GMFCS level = 2 studies (4.9%) Wheelchair dependence = 1 study (2.4%) Spastic quadriplegia (not further specified) = 1 study (2.4%) SRS-24 = 1 study (2.4%) Not reported = 36 (87.8%) | GMFCS level (range of proportions of patients in each category): - GMFCS I = 1.3% to 3.2% - GMFCS II = 4.0% to 31.3% - GMFCS III = 11.1% to 38.5% - GMFCS IV = 21.4% to 56.3% - GMFCS V = 0 to 64.5% Not reported = 4 (33.3%) |
TXA dosing | Number of studies using bolus only = 1 (2.4%) Number of studies using infusion only = 0 Number of studies using bolus and infusion = 23 (56.1%) Range of bolus dose (mg/kg) = 5 to 100 Range of intraoperative infusion dose (mg/kg/h) = 1 to 10 Number of studies with unclear or insufficient reporting = 17 (41.5%) | Number of studies using bolus only = *3 (25.0%) Number of studies using infusion only = 0 Number of studies using bolus and infusion = *7 (58.3%) Range of bolus doses (mg/kg) = 10 to 50 Range of intraoperative infusion dose (mg/kg/h) = 1 to 10 Number of studies with unclear or insufficient reporting = 3 (25.0%) |